Latest
Amgen is Big Pharma’s newest player
Nov. 7, 2011 should be remembered as the date when Amgen resigned its charter membership in the biotech growth club and joined Big Pharma.
Latest
Editorial: Haas drives high-tech manufacturing training
The Oxnard businessman is providing an additional $150,000 in funding to the Society of Manufacturing Engineers Foundation to create a series of Gene Haas Scholarships.
Latest
Post-Madoff era still rife with schemes
Ponzi schemes, insider trading and mortgage fraud have sunk white collar crimes into their lowest nadir since the junk bond era.
Latest
Op/ed: Flat rate would treat all taxpayers equally
The current income tax code punishes our economy, rewards special interests and makes the U.S. less competitive globally.
Latest
Area politics filets eatery’s big dreams
One of the most annoying things about local governments in the Tri-Counties is the widespread phenomenon I call “drive-thru phobia.”
